Document is current
Any future updates will be listed below
-
Authors
Choate, Evan A.
Kaeley, Gurjit S.
Brook, Jenny
Altman, Roy D.
FitzGerald, John D.
Floegel-Shetty, Astrid R.
Elashoff, David A.
Ranganath, Veena K. http://orcid.org/0000-0003-3417-9478
-
Funding
Funding for this research was provided by:
Genentech (ML28542)
Pfizer (WI193025)
- License Information
-
More Information
Article History
Received: 5 August 2019
Accepted: 20 November 2019
First Online: 3 February 2020
Ethics approval and consent to participate
: The study was approved by the UCLA institutional review board (IRB#12–001547, IRB#14–001148). Written consent from study participants was obtained.
: Not applicable.
: EAC: none reported; GSK: none reported; JB: none reported; RDA serves as a consultant for Ferring, Flexion, GSK, Novartis, Olatec, and Pfizer; JF: none reported; ARFS: none reported; DAE: none reported; VKR has received research support and grants from Genentech (IST grant), Pfizer (IST grant), Mallinkrodt (IST grant), BMS (ad board), and Amgen (DSMB).
